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Abstract
Background:  Unrestrained plethysmography has been used to monitor bronchoconstriction
because of its ease of use and ability to measure airway responsiveness in conscious animals.
However, its reliability remains controversial.
Objective: To investigate if unrestrained plethysmography could provide a valid interpretation of
airway responsiveness in allergic BALB/c mice.
Methods: Ovalbumin sensitized BALB/c mice were randomized to receive either a single-dose
Ovalbumin challenge (OVA-1D group) or a three-dose Ovalbumin challenge (OVA-3D group). The
OVA-1D group was further divided into OVA-1D-I (measured invasively, using lung resistance as
the index of responsiveness) and OVA-1D-N group (measured non-invasively, using Penh as the
index of responsiveness). Similarly the OVA-3D group was divided into OVA-3D-I and OVA-3D-
N groups based on the above methods. The control groups were sensitized and challenged with
normal saline. Bronchial alveolar lavage fluid was taken and airway histopathology was evaluated for
airway inflammation. Nasal responsiveness was tested with histamine challenge.
Results: Compared with controls, a significant increase in airway responsiveness was shown in the
OVA-1D-N group (P < 0.05) but not in the OVA-1D-I group. Both OVA-3D-I and OVA-3D-N
groups showed higher responsiveness than their controls (P < 0.05). The nasal mucosa was
infiltrated by eosinophic cells in all Ovalbumin immunized groups. Sneezing or nasal rubbing in
allergic groups appeared more frequent than that in the control groups.
Conclusion: Penh can not be used as a surrogate for airway resistance. The invasive measurement
is specific to lower airway. Penh measurement (done as a screening procedure), must be confirmed
by a direct invasive measurement specific to lower airway in evaluating lower airway
responsiveness.
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Background
Airway hyperresponsiveness (AHR) is a functional abnor-
mality characteristic of bronchial asthma [1]. AHR in
asthma is defined as an exaggerated response of the airway
(lower airway in particular) to a variety of nonspecific
stimuli, resulting in airway obstruction [2,3].
Several measurement techniques which have been used
for the investigation of airway responsiveness (AR) in
mice in vivo include invasive and non-invasive
approaches [4]. Invasive measurements of pulmonary
function are performed in tracheotomized, endotrache-
ally intubated rodents or in orotracheally intubated
rodents. These involve the determination of airway resist-
ance and dynamic compliance, which are the gold stand-
ards in assessing bronchoconstriction. Recently,
unrestrained barometric plethysmography in conscious
mice or rats represents the extreme of non-invasiveness
and has been widely used for measuring airway hyperre-
sponsiveness in murine models of allergic airway inflam-
mation [[5-8], and [9]]. It is attractive because of its ease
of use and its ability to obtain data rapidly and non-inva-
sively, especially in conscious animals. However, contro-
versy remains on its validity to the measurement of airway
responsiveness [10-17] and so far, there has not been suf-
ficient data supporting Penh as a surrogate for airway
resistance [18].
For an insight into the controversy, we measured allergic
mice by both non-invasive and invasive methods, and
compared constriction data measured by Penh to resist-
ance measurements done invasively.
Methods
Animals
One hundred and twenty pathogen-free, female BALB/c
mice, 6–7 weeks of age, 18–20 g body weight, were pur-
chased from Animal Experiment Center of Guangzhou
University of Chinese Medicine. Upon delivery, the mice
were kept in a pathogen-free rodent facility and were pro-
vided food and water ad libitum. The animal experiments
were approved by Animal Experiment Centre of
Guangzhou University of Chinese Medicine.
Sensitization and Airway Challenge
Test mice were sensitized systemically with ovalbumin
(OVA 10 ug/injection, grade V, Sigma, St Louis, MO, USA)
adsorbed to 1.3 mg of aluminum hydroxide gel
[Al(OH)3, Sigma, USA] by intraperitoneal injections on
days 0, 7 and 14. Test mice were challenged by intranasal
instillation of OVA either once on day 28; or three times,
once daily on each of days 28, 29, and 30. 2 mg OVA was
dissolved in 1 ml sterile saline and instilled intranasal into
the mice (100 ug/50 ul OVA solution, 2_per mouse) using
a sterile pipette. Control mice were sensitized and chal-
lenged with diluents.
OVA immunized mice were divided into four groups
based on their treatment and measurement of airway
responsiveness (see Figure 1).
OVA-1D group (N = 32): Mice were sensitized as
described above, and challenged on day 28. On day 29,
airway responsiveness was measured. The group was fur-
ther divided into two sub-groups, namely, the OVA-1D-I
group [measured invasively using "RC"system, Buxco,
USA] and OVA-1D-N group [measured non-invasively
using barometric whole body plethysmography (WBP sys-
tem, Buxco, USA)].
OVA-3D group (N = 32): Mice were sensitized as
described above, and challenged on days 28, 29, and 30.
On day 31, airway responsiveness was measured. The
group was divided again into two sub-groups: OVA-3D-I
Protocol for ovalbumin (OVA) intraperitoneal (i.p.) sensitiza- tion and subsequent OVA intranasal (i.n.) challenge Figure 1
Protocol for ovalbumin (OVA) intraperitoneal (i.p.) 
sensitization and subsequent OVA intranasal (i.n.) 
challenge. Mice were sensitized by an intraperitoneal injec-
tion of 10 μg OVA on days 0, 7 and 14, followed by daily 
intranasal challenges with 0.2% OVA. OVA-1D-N was chal-
lenged on day 28 and airway responsiveness was carried out 
on day 29 by Penh measurements. OVA-1D-I were chal-
lenged on day 28 and airway responsiveness was carried out 
on day 29 by invasive methods. OVA-3D-N were challenged 
on days 28, 29, 30 and airway responsiveness was carried out 
on day 31 by Penh measurements. OVA-3D-I were chal-
lenged on days 28, 29, 30 and airway responsiveness was car-
ried out on day 31 by invasive methods.
Groups  Day  0   7  14       28  29  30  31      
OVA-1D-N 
IP  IP   IP       IN  Sacrificed     
OVA-1D-I 
I P   I P    I P        I N   S a crifice d    
OVA-3D-N 
IP  IP   IP       IN  IN  IN  Sacrificed     
OVA-3D-I 
IP  IP   IP       IN  IN  IN  Sacrificed    Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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group measured invasively, and OVA-3D- N group, meas-
ured noninvasively.
Control group((N = 56): Mice were sensitized and chal-
lenged with normal saline; using the same volume of
solution as used in the OVA-treated mice, applied both
i.p. and i.n., respectively.
Airway Responsiveness Measurement
Penh measurements (Non-invasive approach)
Airway responsiveness was assessed using a single-cham-
ber, whole body plethysmograph (WBP system, Buxco,
USA) as described by Hamelmann and coworkers [5]. In
this system, an unrestrained and spontaneously breathing
mouse was placed into the main chamber of the plethys-
mograph; the plethysmograph was calibrated by injecting
1 ml of air before the measurements. In the plethysmo-
graph, mice were exposed for 1.5 minutes to nebulized
normal saline (Aerogen nebulizer head, particle size 4–6
um mass median aerodynamic diameter, licensed by
Buxco, USA) and subsequently to increasing concentra-
tions of nebulized MCh (0.39–50 mg/ml; Sigma, USA).
When the animal inspires, air is removed from the cham-
ber, and enters the lungs, driving the chamber pressure
down (nasal flow) at the same time, however, the lungs
expand, increasing the chamber pressure (thoracic flow).
The thoracic expansion on inspiration is always greater
than the volume of air withdrawn from the chamber, for
two reasons: First, thermodynamic effects come into play.
The air from the chamber is heated and humidified once
it is in the animal. Therefore the increase in chest or tho-
racic volumes somewhat larger than the air removed from
the chamber through the nose. Secondly, there may be
compression and rarefaction effects within the lungs due
to effort of breathing, and these effects may be more
prominent in particular regions of the respiratory cycle. If
there is an obstruction, or a constriction in the airways,
and the musculature moves the thorax, without a con-
comitant nasal or head flow response, the difference
between the chest and nasal flows increases. The differ-
ence between the thoracic expansion and the air removed
from the chambers creates the respiratory signal (box
flow) that is measured in WBP system.
From the box flow signal, we derived: Inspiratory time
(TI); expiratory time (TE); relaxation time (TR), the time
for the expiratory area to decline to 36% of the total expir-
atory area; peak inspiratory flow(PIF) and peak expiratory
flow (PEF); tidal volume (VT); minute ventilation (VE);
and respiratory rate (RR); Pause (= [TE-TR]/TR); and Penh
(=pause PEF/PIF). Penh is considered an empiric parame-
ter that reflects changes in waveform of the measured box
pressure signal as consequence of bronchoconstriction.
After the end of aerosolization, the Penh values were
measured during each 3-min sequence, as well as the
mean of each MCh concentration, and presented as the
percent changes from corresponding baseline values. The
provocative concentrations of the agonist that increased
Penh to 200% and 300% of baseline (PCPenh200,
PCPenh300) were obtained by linear interpolation of the
concentration response curve between the final two doses
of the respective provocative agent [19,20]. There were 12
untreated mice tested by Penh measurements for each
subgroup.
Invasive approach
Using the invasive measurement system ("RC" system,
Buxco, USA), pulmonary measurements are performed in
tracheotomized, endotracheally intubated (stainless steel
cannula, 18 gauge) mice. These techniques had been
described before [21]. Briefly; mice were anesthetized
with intraperitoneal injections of sodium pentobarbital
(70 to 90 mg/kg body weight) with minimal supplemen-
tations as required. When an appropriate depth of
anesthesia was achieved, as monitored by a loss of the
righting and pinch toe reflex, mice were tracheotomized,
endotracheally intubated and connected to a ventilator
(Model 683, Harvard, USA), then ventilated with a tidal
volume of 180–190 ul and a respiratory frequency of 125
times of breath. The animals were then placed supine in a
whole body plethysmograph. The endotracheal tube was
connected to a manifold with three multiple ports outside
the chamber: two ports for connections to the ventilator,
and one port to a differential pressure transducer for mon-
itoring of tracheal pressure. Esophageal pressure was
monitored via water filled tubing (CNS1010, Buxco,
USA), and connected to the other port of the differential
pressure transducer. Thus transpulmonary pressure, Ptp,
(tracheal – esophageal), was monitored and used in the
computations. The esophageal tubing was inserted to the
level of the midthorax. The optimal position of the tube
was in the lower third of the esophagus where we moni-
tored maximum negative pressures.
Airflow was monitored by a pneumotachograph in the
wall of the plethysmograph. The pressure within the
plethysmograph monitored the flow due to the animal's
thoracic movements. Lung resistance was determined
from the ratio of Ptp to tidal flow over an entire breath
cycle. The signals of flow and transpulmonary pressure
were recorded on a computer. Respiratory volume was
obtained by digital integration of the flow signal so that
RL (lung resistance) was calculated from the transpulmo-
nary pressure and flow at isovolumetric points. After the
end of aerosolization, the RL values were measured during
each 3-min sequence as the mean for each MCh concen-
tration, and presented as the percent changes from corre-
sponding baseline values. Before each experiment,
calibrations of flow and pressure were performed with a
volume of 1 ml of air and pressures of 0 and 20 cmH2O,
respectively.Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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Lung Pathological Analyses
Bronchoalveolar Lavage Analysis
After AR measurements, animals were euthanized by
injection with a lethal dose of a pentobarbital-based
euthanasia solution. Blood was collected by cutting the
renal artery. Their tracheas were cannulated, and their
chests were opened. Bronchoalveolar lavage (BAL) cells
were obtained by inserting a catheter into the trachea and
lavaging the lung three times with 0.8 ml of phosphate-
buffered saline (PBS). Approximately, 2.0 ml BAL fluids
was consistently recovered with gentle handling. The
retrieved lavage aliquots were pooled and centrifuged at 4
degrees Celsius, 1500 rpm for 10 min, from which the cell
pellet was resuspended in PBS and counted using a hemo-
cytometer. Slide smears were treated with hematoxylin-
eosin stain (Sigma, USA) for differential cell counts with
at least 300 leukocytes in each sample. Stained slides were
read randomly and in a blinded manner. The cell types
were judged according to standard hemocytologic proce-
dures as neutrophils, eosinophils, lymphocytes, or macro-
phages. The data were obtained from seven mice per
group after AR measurement.
Bronchial histopathology
After blood collection, some animals had their lungs
instilled via the trachea with 10% buffered formalin,
removed, and fixed in the same solution. Animals used for
histopathologic analysis were not subjected to BAL. After
paraffin embedding, sectioned at 4 um, and stained with
hematoxylin and eosinphloxin (H&E), histopathological
assessment (light microscopy) was performed blind on
randomized sections. Inflammatory changes were graded
using a semiquantitative scale of 0–5 for perivascular eosi-
nophilia, bronchiolar eosinophilia, epithelial damage
and oedema as previously described [22]: scale of 0
(none), 1 (minimal), 2 (mild), 3 (moderate), and 4
(severe). Individual lesion scores were summed from each
animal to create an overall histopathology score for each
animal. A pathologist who was blinded to the exposure
conditions evaluated all slides. The data were obtained
from four to five mice per group after AR measurement.
Analysis of upper airway
Nasal challenge with histamine
In another test, OVA-1D and OVA 3D mice (and their
controls) which followed the study design as described
before, were challenged with histamine (n = 8 for each
group). Because mice are preferential nose breathers,
small droplets of solution were placed on the external
naris of awake mice to be drawn into the nasal passages
during inhalation. As described by Klemens J [23], the
nasal challenge with histamine consisted of intranasal
application of 50 μl of various concentrations of hista-
mine (Sigma, USA) applied gradually over 2 minutes. The
challenge involved 3 exposures to histamine (0.3 mM, 3.0
mM, and 30 mM). After each exposure, allergen-induced
nasal symptoms were evaluated by counting the number
of sneezes and nasal itching motions (nasal rubbing) that
occurred within a 10-min interval by the same investiga-
tor who was blinded to the treatment groups.
Infiltration of Eosinophils in Nasal Mucosa and nasopharynx Mucosa
After AR measurements by Penh measurements, the mice
were skinned, fixed for 48 h in buffered formalin (10%)
at 20 degrees Celsius and decalcified during 2 weeks using
a 14% ethylenediamineteraacetic acid (Sigma, USA) solu-
tion. Coronal sections of the skulls in the middle and the
third between nose-tip and orbit were made and stored in
formalin until further processing. After dehydration and
embedding in paraffin, a thickness of 4 μm, the specimens
were then deparaffinized and stained with hematoxylin-
eosin. Representative nasal sections were scored by count-
ing eosinophils in (sub)-epithelial layers of both lateral
nasal walls by using an eyepiece reticule. The number of
eosinophils was quantified per unit (1 mm2) of lateral
nasal walls length (between the lower edge of the upper
turbinate and the upper edge of the middle turbinate; the
lower edge of the middle turbinate and the upper edge of
the lower turbinate; the lower edge of the lower turbinate
and nose-tip) (Figure 2). The data were obtained from
nine to ten mice per group after AR measurement by non-
invasive approach.
Statistical Analysis
For all cell counts, stained slides were read randomly and
in a blinded manner. All statistical analyses were per-
formed using SPSS 12.0 Version package (SPSS Inc., Chi-
cago, IL). The percentage of BAL cells, inflammatory
lesion scores of lung and the infiltration numbers of eosi-
nophils in nasal were expressed as median and interquar-
tile range (IQR). Normal-distributed data were compared
using analysis of variance (ANOVA) or unpaired t test,
whereas the non-parametric Kruskal-Wallis test was used
otherwise. If significant differences have been found, Bon-
ferroni test was used as a multiple comparative test to
evaluate the differences in nasal and lower airway hyper-
responsiveness. All hypothesis testing was two-sided and
P < 0.05 was defined as significant.
Results
Airway Responsiveness
There were 12 untreated mice tested for lung mechanics in
each group. One mouse in each of OVA-1D-I group and
Control group died during cannulating trachea. One
mouse in OVA-3D-I group died of anesthesia. These mice
were not included in the analysis. 93 mice completed the
test satisfactorily.
24 hours after final exposure, mice were assessed for AR by
Mch challenge. The OVA-1D -I group, measured inva-Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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sively for resistance, did not have an increase in AR in
comparison to control mice (see Figure 3A). In contrast,
the OVA-1D- N group which had the same allergen sensi-
tization and challenge protocol as OVA-1D-I group
showed a significant increase in AR at MCh concentra-
tions of 6.25 – 25 mg/ml as measured by Penh measure-
ments (see Figure 3B). In addition, Penh 200 and Penh
300 decreased significantly in OVA-1D- N group when
compared with the control group (see Figure 3C). Both
OVA-3D-N and OVA-3D-I groups presented with airway
hyperresponsiveness (see Figures 3D, E). Compared with
the control group, airway hyperresponsiveness in OVA-
3D-N group was shown at MCh concentrations of 0.78–
50 mg/ml but at MCh concentrations of 12.5 – 50 mg/ml
in OVA-3D-I group.
Lung Pathological Analyses
Bronchoalveolar Lavage Analysis
There was no difference in the percentage of BAL cells
between the controls of all four test groups. The control
data for the OVA-1D-I group was chosen for comparison
to all test groups. As indicated in Table 1, the percentage
of BAL neutrophils and eosinophils increased and the per-
centage of BAL macrophages significantly decreased in all
OVA immunized mice when compared with the control
group. The percentage of eosinophils in BALF of OVA-3D-
I group was significantly higher than that of OVA-1D-I
group (P < 0.05). There were no differences in the percent-
age of BAL lymphocytes, neutrophils, macrophages and
eosinophils between OVA-1D-I and OVA-1D-N group or
between OVA-3D-I and OVA-3D-N group (see Table 1).
Bronchial histopathology
There was no difference in inflammatory lesion scores
between the controls of all four test groups. The control
data for the OVA-1D-I group was chosen for comparison
to all test groups. There were no differences in inflamma-
tory lesion scores between the OVA-1D-I and the OVA-
1D-N group (see Table 2, Figure 4B and 4D) or between
the OVA-3D-I and the OVA-3D-N groups. Mice in the
OVA-3D group had higher inflammatory lesion scores
than those in the OVA-1D group (see Table 2, Figure 4B–
F). Inflammation in OVA-1D mice consisted of minimal-
to-mild inflammation in peribronchiolar and perivascular
interstitial infiltrates of eosinophils, neutrophils and mac-
rophages mixed with occasional plasma cells and rare
lymphocytes (see Figure 4B and 4C) while OVA-3D mice
showed moderate-to-severe inflammatory responses in
the peribronchovascular connective tissue sheaths sur-
rounding arteries and airways (see Figure 4D, E and 4F).
Moreover, in OVA-3D mice, macrophages and eosi-
nophils occasionally widened alveolar septa slightly in the
parenchyma (see Figure 4F) and a few eosinophils along
with a few macrophages were present in alveolar septa
(either interstitial or within the capillary bed).
Analysis of upper airway
Nasal challenge with histamine
As shown in Figure 5, the number of sneezes in OVA-3D
mice was significantly higher than that in OVA-1D mice
and control mice for 30 mM-histamine. In OVA-1D mice,
the number of nose rubs was significantly higher than
control mice for 30 mM-histamine. In addition, the
number of nose rubs in OVA-3D mice was significantly
higher than control mice for 3 and 30 mM-histamine and
higher than OVA-1D mice just at 30 mM-histamine.
Infiltration of Eosinophils in Nasal and Pharyngeal Portion Mucosa
Both in OVA-1D group and OVA-3D group, there was
obvious inflammation in upper airway [see figure 6].
On day 29 after assessment of pulmonary mechanics,
upper airway histology showed mild inflammatory
responses in pharyngeal mucosa of OVA-1D group mice,
with mild infiltration of few eosinophils and neutrophils.
On day 31 after assessment of pulmonary mechanics,
mild to moderate inflammation could be seen in OVA-3D
group mice with mild to moderate infiltration of eosi-
nophils, neutrophils mixed with occasional macrophages.
Light microscopic images of the murine nose (50 fold magnifi- cation) of a coronal section through the sinonasal skeleton,  showing the murine nasal anatomy Figure 2
Light microscopic images of the murine nose (50 fold 
magnification) of a coronal section through the sino-
nasal skeleton, showing the murine nasal anatomy. 
Eosinophils were counting in a defined region of the nasal 
mucosa (along red line).Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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The nasal inflammatory infiltrate in OVA immunized
mice was present mainly in the subepithelial layer along
the edge of the upper turbinate and consisted primarily of
infiltrating eosinophils and mononuclear cells (see Figure
7). The median number of eosinophils in the nasal sub-
epithelium in both OVA immunized groups were higher
than in the control group (0.00/um, range 0–5.03) (P >
0.05), but there were no differences between OVA-1D-N
group (median 10.55/um, range 4.16–33.62) and OVA-
3D-N group (median 6.69/um, range 1.11–48.91).
Discussion
Traditional invasive pulmonary function tests have been
shown to be sensitive in detecting bronchoconstriction in
mice. This method appears precise and specific, because
the nasal exposure is excluded, thus focusing on the inha-
lation exposure to the lungs. However, the need for
anesthesia and invasive procedures such as tracheotomy
or orotracheal intubation, and mechanical ventilation
makes this approach a study of animals under conditions
far from natural [11,13].
On the other hand, the highly reproducible Penh meas-
urements seem to be suitable for repeated pulmonary
measurements, e.g. in long-term follow-up studies, or in
asthma models with assessment of early airway response
and late airway hyperresponsiveness in the same animal.
However, its validity remains controversial. Albertine et al
[14] and Petak et al [15] have shown that there is an
inconsistent relationship between Penh and invasive
24 hours after final exposure, mice were assessed for airway responsiveness to Mch challenge Figure 3
24 hours after final exposure, mice were assessed for airway responsiveness to Mch challenge. (A), (B) and (C) 
are OVA sensitized with single-dose OVA challenge, measured invasively (A, OVA-1D-I, squares on solid line) or by Penh 
measurements (non-invasively) (B, OVA-1D-N, squares on solid line). (D) and (E) are OVA sensitized with three-dose OVA 
challenge, measured invasively (D, OVA-3D-I, triangles on solid line) or by Penh measurements (E, OVA-3D-N, triangles on 
solid line). *P < 0.05 compared with controls (circles on dotted line).
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measurements, especially in C57BL/6 mice. Enhorning et
al [16], Lundblad et al [17] and Mitzner et al [24] have
shown that the relationship between the chamber pres-
sure, from which Penh is calculated, and the airway resist-
ance is limited. Hamelmann et al [5], demonstrated that
the responsiveness of allergen-sensitized mice to metha-
choline, as measured with the WBP system, paralleled the
responsiveness of airway resistance, as measured inva-
sively. He concluded that the non-invasive barometric
plethysmography provided a new opportunity to evaluate
the mechanism and kinetics underlying the development
and the maintenance of airway responsiveness. However,
in his study, Penh and RL were not obtained on the same
day of the protocol (Penh was measured on Day 31 of the
protocol and RL was obtained on day 32). In our experi-
ence, eosinophils cell counts in bronchial alveolar lavage
fluid and airway histopathology (data not shown) pre-
sented different airway inflammation on different days of
the protocol.
Because there are not currently sufficient data as to con-
clude whether Penh could be used to detect and measure
airway responsiveness, we used both Penh and invasive
measurements to investigate AR in BALB/c mice which
had undergone the same sensitization and challenge pro-
tocol. As shown in our results, the OVA-1D group had
mild inflammation while the OVA-3D group had severe
inflammation in the lung. In contrast to Penh measure-
ments, the invasive measurement showed no increase in
AR compared to control mice for the mild inflammation
group. Furthermore, compared with the control group,
airway hyperresponsiveness measured by Penh measure-
ments in severe inflammation group was found in lower
MCh concentrations than that which measured by inva-
sive measurements.
Some experts argue that anesthesia or the trauma of intu-
bations may affect, to some extent, the airway responsive-
ness. But it should be noted that in this study, the
comparison was only made between the allergic mice and
the control mice in the same condition.
Table 1: Median (IOR) differential cell counts (%) in BALF
Macrophages (%) Lymphocytes (%) Neutrophils (%) Eosinophils (%) Total Cells (*105/ml)
OVA-1D-I 42.79(37.61) 12.50(17.85) 21.63(36.20) 23.20(18.42) 2.90(1.10)
OVA-1D-N 37.95(22.99) 6.50(2.10) 27.57(13.10) 23.20(15.17) 2.70(1.00)
OVA-3D-I 32.27(33.68) 7.17(11.89) 11.16(9.10) 40.36(18.54)† 7.30(2.70)††
OVA-3D-N 30.41(3.58) 8.00(16.76) 8.57(12.20) 48.71(11.70) 8.80(3.50)
Control(I) 89.13(12.54)* 7.81(17.46) 0.93(3.20)* 0.00(0.00)* 1.10(0.50)*
All mice were sensitized with OVA (10 ug, i.p) on days 0, 7 and 14. Mice in OVA-1D group were single-dose challenged on day 28. On day 29, 
responsiveness of mice was carried out with invasive measurements (OVA-1D-I group) or non-invasive measurements (OVA-1D-N group). Mice in 
OVA-3D group were three-dose challenged on day 28, 29, 30. On day 31, responsiveness of mice was carried out by invasive (OVA-3D-I group) or 
Penh measurements (OVA-3D-N group). The mice in Control (I) group were sensitized and challenged with normal saline.
*P ≤ 0.01 for Control group versus OVA immunized group, Kruskal-Wallis test.
†P < 0.05 for OVA-3D-I group versus OVA-1D-I group, Kruskal-Wallis test.
††P ≤ 0.001 for OVA-3D-I group versus OVA-1D group (single-dose OVA challenge), Kruskal-Wallis test.
Representative hematoxylin and eosin-stained lung sections  collected after assessment of pulmonary mechanics from  mice Figure 4
Representative hematoxylin and eosin-stained lung 
sections collected after assessment of pulmonary 
mechanics from mice. (B) and (C) is OVA sensitized with 
single-dose OVA challenge, measured invasively (B) or by 
Penh measurements (C). (D), (E) and (F) are OVA sensitized 
with three-dose OVA challenge, measured invasively (D) or 
by Penh measurements (E, F).
A Control
E             O V A- 3 D - N   F            O V A- 3 D - N  
B          OVA-1D-I
C            O V A- 1 D - N   D             O V A- 3 D - I  Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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At the time of Penh measurements, the number of sneezes
or nasal itching in most allergic mice in response to Mch
was significantly higher in comparison to control mice. So
we hypothesized that Penh value in unrestrained plethys-
mography in conscious mice might include the contribu-
tion of upper airway resistance and it could reflect airflow
limitation in the upper airway, including the nasal cavity,
larynx and pharynx, etc. As we know, in humans, nasal
resistance contributes about 50% of the respiratory resist-
ance [5]. When AR is measured in humans, Mch or hista-
mine is usually inhaled via mouth and nose clips are used
during the testing. However, it is impossible for mice to
adapt to such a protocol.
In addition, we had further analyzed the characteristics of
the upper airway of the experiment mice, including the
histology and nasal challenge with histamine. The sneez-
ing or nasal itching in airway allergic groups was signifi-
cantly more frequent than that in control groups. The
histological study clearly showed infiltration of inflam-
matory cells in the nasal mucosa of allergic mice. The
present findings suggested that airflow limitation in the
upper airway, including the nasal cavity, might affect the
value of Penh, and include an uncertainty in the exact
magnitude of bronchoconstriction. Our results demon-
strate that the increased upper airway resistance is the
major factor influencing Penh, therefore, the changes in
Penh may not be a reliable indicator of change of lower
airway responsiveness, at least in mild Ovalbumin sensi-
tized BALB/c mice.
A recent report shows that Penh can be influenced by
increases in upper airway resistance, while the lower air-
way was unaffected in their model. Nakaya et al [25] has
described an application of the Penh system to study nasal
hypersensitivity, suggesting that the non-invasive system
could be very useful in the study of nasal hypersensitivity.
Furthermore, Taw Tsumuro et al[26] evaluated nasal con-
gestion in rats using whole body plethysmography, and
noted that Penh increased significantly following the
intranasal application of histamine in Toluene-2, 4-diiso-
cyanate (TDI) sensitized rats, indicating the changes in
Penh, induced by TDI challenge reflected upper airway
congestion in their model. Anurag et al [27], Using Dou-
ble-chamber plethysmography, showed that nasal resist-
ance change comprises one-half or more of the total
resistance change during methacholine challenge.
The other possibility we need to point out is that mice are
preferential but not obligate nasal breathers [27]. After
nasal occlusion, most mice switch to an oral mode of
breathing with no apparent discomfort. Histamine may
lead to a change in the pattern of breathing and then it can
also make Penh well changed.
This study showed that invasive and Penh measurements
might lead to the different results for airway responsive-
ness in the same mildly allergic mice group. One of the
explanations may be that the airway inflammation of the
mild allergic mouse was comparatively mild, which lead
to modest bronchoconstriction in the lower airway. It had
been shown that not all airway inflammation leads to air-
way hyperresponsiveness. For example, nonasthmatic
eosinophilic bronchitis (NAEB) is a newly recognized
cause of chronic cough in human [28]. It is characterized
by the presence of eosinophilic airway inflammation,
similar to that seen in asthma. However, in contrast to
asthma, nonasthmatic eosinophilic bronchitis is not asso-
ciated with variable airflow limitation or airway hyperre-
sponsiveness [29]. Another explanation may be that
inhalation exposure includes nasal and gastro-intestinal
uptake by Penh measurements. Penh may pick up all
sources of resistance, upper airway as well as lower airway,
and it might not necessarily represent a change in the
lower respiratory tract. The increased airway responsive-
ness in Penh measurements may be related to obstruction
of upper airway but not of lower airway in some models.
In contrast to mildly allergic models, the change of Penh
in moderately or severely allergic mice may be derived
from both upper and lower airway resistance.
Table 2: Inflammatory lesion scores in OVA immunized group and control group
Different group Perivascular eosinophilia Peribronchiolar eosinophilia Edema Epithelial damage
OVA-1D-I 3(1–3) 1(1–2) 1(1–2) 1(1–3)
OVA-1D-N 3(2–3) 1(1–2) 1(1–2) 1(1–3)
OVA-3D-I 4(3–5)† 2.5(2–3)† 1(1–2) 2(1–3)
OVA-3D-N 3.5(3–5)† 2(2–3)† 1(1–2) 2(1–3)
Control(I) 0(0–0)* 0(0–0)* 0(0–0)* 0(0–1)*
All mice were sensitized with OVA (10 ug, i.p) on days 0, 7 and 14. Mice in OVA-1D group were single-dose challenged on day 28. On day 29, 
responsiveness of mice was carried out with invasive measurements (OVA-1D-I group) or non-invasive measurements (OVA-1D-N group). Mice in 
OVA-3D group were three-dose challenged on day 28, 29, 30. On day 31, responsiveness of mice was carried out by invasive (OVA-3D-I group) or 
Penh measurements (OVA-3D-N group). The mice in Control (I) group were sensitized and challenged with normal saline.
* P < 0.05 for Control group versus OVA immunized group, Kruskal-Wallis test.
†P < 0.01 for OVA-3D group versus OVA-1D group, Kruskal-Wallis test.Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
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Based on our study, at least in mild ovalbumin-sensitized
BALB/c mice, Penh cannot be used as a surrogate for air-
way resistance when sensitivity to cholinergic stimulation
is studied. It is likely that Penh contains upper airway
resistance components as well as lower airway resistance
components. It is not clear how much is upper airway
resistance and how much is lower airway resistance. Such
an effect is bypassed by the tracheotomy or orotracheal
intubations in the invasive measurement. Therefore, in
evaluating lower airway responsivity, a Penh measure-
ment (done as a screening procedure), must be confirmed
by a direct invasive measurement specific to lower airway.
Conclusion
In mildly allergic mice, the increased airway resistance as
shown with non-invasive measurement may be due to
upper airway resistance. In moderately or severely allergic
mice, the increased airway resistance may be derived from
both upper and lower airway. The invasive measurement
is specific in measuring lower airway resistance.
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Representative hematoxylin and eosin-stained pharyngeal  portion mucosa collected after airway responsiveness meas- ured by Penh measurements Figure 6
Representative hematoxylin and eosin-stained pha-
ryngeal portion mucosa collected after airway 
responsiveness measured by Penh measurements. 
(A) Light Microscopic image (50 fold magnification) of Con-
trol mice. (B) Magnification of (A), 400 fold magnification. (C) 
OVA sensitized with single-dose OVA challenge, airway 
responsiveness was carried out by Penh measurements. (D) 
OVA sensitized with three-dose OVA challenge, airway 
responsiveness was carried out by Penh measurements.
A           C ontrol  B         C ontrol 
C          O V A- 1 D - N   D          O V A- 3 D - N  Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
Page 10 of 11
(page number not for citation purposes)
design of the experiments, data analysis, and preparation
of the manuscript. All authors participated in manuscript
design and revisions and approved the final manuscript.
Acknowledgements
This work was supported by the National Natural Science Foundation of 
China (Grant No.30670934) and in part by Guangzhou Municipal Science 
and Technology Project (grant No.2002Z2-E0091). The authors gratefully 
acknowledge the contributions of the Chronic Cough Team of State Key 
Laboratory of Respiratory Disease (Guangzhou Medical University)©, the 
First Affiliated Hospital of Guangzhou Medical University: Wei Luo, 
Ruchong Chen, Yanqing Xie, Qiaoli Chen, Chunli Liu, Binkai Li, Faxia Wang, 
Lu Shen, and Yanbing Zheng. We thank Dr. Guangqiao Zeng for assistance 
with the manuscript, and Mrs. Mei Jiang for assistance in statistical consid-
erations. We also thank all investigators and local administrations for their 
great assistance in field surveying in this study.
References
1. National Heart, Lung, and Blood Institute and GINA Executive Com-
mittee:  Global Initiative for Asthma. Global Strategy for
Asthma Management and Prevention.  GINA_Report_2006
Chapter1DEFINITION AND OVERVIEW 2007:8.
2. O'Byrne PM, Inman MD: Airway hyperresponsiveness.  Chest
2003, 123:411S-416S.
3. Postma DS, Kerstjens HA: Characteristics of airway hyperre-
sponsiveness in asthma and chronic obstructive pulmonary
disease.  Am J Respir Crit Care Med.  1998, 158(5 Pt 3):S187-S192.
4. Hoymann HG: Invasive and noninvasive lung function meas-
urements in rodents.  J Pharmacol Toxicol Methods.  2007,
55(1):16-26.
5. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG,
Gelfand EW: Noninvasive measurement of airway responsive-
ness in allergic mice using barometric plethysmography.  Am
J Respir Crit Care Med 1997, 156(3 Pt 1):766-775.
6. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE,
Brenneise IE, Horton MA, Haczku A, Gelfand EW, Leikauf GD, Lee
NA: Interleukin-5 expression in the lung epithelium of trans-
genic mice leads to pulmonary changes pathognomonic of
ashma.  J Exp Med.  1997, 185(12):2143-2156.
7. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW: Res-
piratory syncytial virus infection results in airway hyper
responsiveness and enhanced airway sensitization to aller-
gen.  J Clin Invest 1997, 100:226-233.
8. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV,
Thorne PS, Krieg AM: Modulation of airway inflammation by
CpG oligonucleotides in a murine model of asthma.  J Immunol
1998, 160:2555-2559.
9. Nakagome K, Dohi M, Okunishi K, Komagata Y, Nagatani K, Tanaka
R, Miyazaki J, Yamamoto K: In vivo IL-10 gene delivery sup-
presses airway eosinophilia andhyperreactivity by down-reg-
ulating APC functions and migration without impairing the
antigen-specificsystemic immune response in a mouse
model of allergic airway inflammation.  J Immunol.  2005,
174(11):6955-6966.
10. Adler A, Cieslewicz G, Irvin CG: Unrestrained plethysmography
is an unreliable measure of airway responsiveness in BALB/c
and C57BL/6 mice.  J Appl Physiol.  2004, 97(1):286-292.
11. Bates JH, Irvin CG: Measuring lung function in mice: the pheno-
typing uncertainty principle.  J Appl Physiol. 2003,
94(4):1297-1306.
12. Schwarze J, Hamelmann E, Gelfand EW: Barometric whole body-
plethysmography in mice.  J Appl Physiol 2005, 98:1955-1957.
13. Irvin CG, Bates JH: Measuring the lung function in the mouse:
the challenge of size.  Respir Res 2003, 4:4.
14. Albertine KH, Wang L, Watanabe S, Marathe GK, Zimmerman GA,
McIntyre TM: Temporal correlation of measurements of air-
way hyperresponsiveness in ovalbumin-sensitized mice.  Am J
Physiol Lung Cell Mol Physiol. 2002, 283(1):L219-L233.
15. Petak F, Habre W, Donati YR, Hantos Z, Barazzone-Argiroffo C:
Hyperoxia-induced changes in mouse lung mechanics:
forced oscillations vs barometric plenthysmography.  J Appl
Physiol. 2001, 90(6):2221-2230.
16. Enhorning G, van Schaik S, Lundgren C, Vargas I: Whole-body
plethysmography, does it measure tidal volume of small ani-
mals?  Can J Physiol Pharmacol.  1998, 76(10-11):945-951.
17. Lundblad LK, Irvin CG, Adler A, Bates JH: A reevaluation of the
validity of unrestrained plethysmography in mice.  J Appl Phys-
iol.  2002, 93(4):1198-1207.
18. Finkelman FD: Use of unrestrained, single-chamber baromet-
ric plethysmography to evaluate sensitivity to cholinergic
stimulation in mouse models of allergic airway disease.  J
Allergy Clin Immunol.  2008, 121(2):334-335.
19. Hoffman AM, Dhupa N, Cimetti L: Airway reactivity measured
by barometric whole body plethysmography in healthy cats.
Am J Vet Res.  1999, 60(12):1487-1492.
20. Hirt RA, Dederichs D, Boehler A, Hoffman AM: Relationship of
age, sex, body weight, and hematologic and respiratory var-
iables with airway reactivity in adult cats.  Am J Vet Res.  2003,
64(1):26-31.
21. Lukacs NW, Glovsky MM, Ward PA: Complement-dependent
immune complex-induced bronchial inflammation and
hyperreactivity.  Am J Physiol Lung Cell Mol Physiol 2001,
280:L512-L518.
22. Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson JA: Time-
course of antigen-induced airway inflammation in the
guinea-pig and its relationship to airway hyperresponsive-
ness.  Eur Respir J.  1995, 8(12):2104-2113.
23. Klemens JJ, Kirtsreesakul V, Luxameechanporn T, Naclerio RM:
Acute Bacterial Rhinosinusitis Causes Hyperresponsiveness
to Histamine Challenge in Mice.  Arch Otolaryngol Head Neck Surg.
2005, 131(10):905-910.
24. Mitzner W, Tankersley C: Interpreting Penh in mice.  J Appl Phys-
iol 2003, 94:828-831.
Representative hematoxylin and eosin-stained nasal mucosa  collected after airway responsiveness measured by Penh  measurements (A) Light Microscopic image (50 fold magnifi- cation) of Control mice Figure 7
Representative hematoxylin and eosin-stained nasal 
mucosa collected after airway responsiveness meas-
ured by Penh measurements. (A) Light Microscopic 
image (50 fold magnification) of Control mice. (B) Magnifica-
tion of (A), 400 fold magnification. (C) OVA sensitized with 
single-dose OVA challenge, airway responsiveness was car-
ried out by Penh measurements. (D) OVA sensitized with 
three-dose OVA challenge, airway responsiveness was car-
ried out by Penh measurements.
C OVA-1D-N D OVA-3D-N
BC o n t r o l AC o n t r o lPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2009, 10:61 http://respiratory-research.com/content/10/1/61
Page 11 of 11
(page number not for citation purposes)
25. Nakaya M, Dohi M, Okunishi K, Nakagome K, Tanaka R, Imamura M,
Baba S, Takeuchi N, Yamamoto K, Kaga K: Noninvasive system for
evaluating allergen-induced nasal hypersensitivity in murine
allergic rhinitis.  Lab Invest.  2006, 86(9):917-926.
26. Tsumuro T, Alejandra Hossen M, Kishi Y, Fujii Y, Kamei C: Nasal
congestion model in Brown Norway rats and the effects of
some H1-antagonists.  Int Immunopharmacol. 2006, 6(5):759-763.
27. Agrawal A, Singh SK, Singh VP, Murphy E, Parikh I: Partitioning of
nasal and pulmonary resistance changes during noninvasive
plethysmography in mice.  J Appl Physiol.  2008,
105(6):1975-1979.
28. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE:
Chronic cough: eosinophilic bronchitis without asthma.  Lan-
cet.  1989, 17(8651):1346-1348.
29. Brightling CE: Chronic Cough Due to Nonasthmatic Eosi-
nophilic Bronchitis. ACCP Evidence-Based Clinical Practice
Guidelines.  Chest.  2006, 129(1 Suppl):116S-121S.